Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome. Issue 4 (4th July 2018)
- Record Type:
- Journal Article
- Title:
- Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome. Issue 4 (4th July 2018)
- Main Title:
- Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome
- Authors:
- Tsukui, Daisuke
Kanda, Hiroko
Shinozaki-Ushiku, Aya
Tateishi, Shoko
Takeshima, Yusuke
Nagafuchi, Yasuo
Sasaki, Oh
Iwasaki, Yukiko
Harada, Hiroaki
Shibuya, Mihoko
Sumitomo, Shuji
Shoda, Hirofumi
Kubo, Kanae
Fujio, Keishi
Nakamura, Fumihiko
Kurokawa, Mineo
Fukayama, Masashi
Yamamoto, Kazuhiko - Abstract:
- Abstract: Objectives: The characteristics of lymphoproliferative disorders (LPD) in patients with rheumatoid arthritis (RA) remain unclear. Therefore, we retrospectively analyzed the clinical characteristics of these patients in our department. Methods: Twenty RA patients who developed LPD between April 2003 and August 2016 in our department were analyzed. Results: All of the RA patients who developed LPD had been treated with methotrexate (MTX). The median weekly and total dosages of MTX were 6.8 mg/week and 2530 mg, respectively. The median duration of MTX administration was eight years. Nineteen patients (95%) achieved complete remission (CR) and 15 (75%) achieved CR with MTX cessation alone. Based on the pathological findings, we divided MTX-associated LPD patients into two groups ( n = 16); polymorphic LPD (31%) and other groups. CR with MTX cessation alone was achieved in 5 (100%) and 6 (54.5%) patients in the polymorphic LPD and other groups, respectively ( p = .12). Moreover, the duration from the cessation of MTX to CR was significantly shorter in the polymorphic LPD group than in the other group (5.3 months vs 12.6 months, p = .01, respectively). Conclusion: Polymorphic LPD, which was the most frequent pathological diagnosis in this cohort, was associated with a higher incidence of CR and a significantly shorter duration to CR.
- Is Part Of:
- Modern rheumatology. Volume 28:Issue 4(2018)
- Journal:
- Modern rheumatology
- Issue:
- Volume 28:Issue 4(2018)
- Issue Display:
- Volume 28, Issue 4 (2018)
- Year:
- 2018
- Volume:
- 28
- Issue:
- 4
- Issue Sort Value:
- 2018-0028-0004-0000
- Page Start:
- 621
- Page End:
- 625
- Publication Date:
- 2018-07-04
- Subjects:
- Rheumatoid arthritis -- methotrexate -- lymphoproliferative disorders -- MTX-associated LPD -- polymorphic LPD
Rheumatology -- Periodicals
616.723005 - Journal URLs:
- http://firstsearch.oclc.org ↗
https://academic.oup.com/mr ↗
https://www.tandfonline.com/journals/imor20 ↗
http://informahealthcare.com/loi/mor ↗
http://link.springer-ny.com/link/service/journals/10165/index.htm ↗
http://link.springer.com/journal/10165 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14397595.2017.1387223 ↗
- Languages:
- English
- ISSNs:
- 1439-7595
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5895.300000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 6890.xml